The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AMC075: A randomized phase II trial of vorinostat with R-EPOCH in aggressive HIV-related NHL.
 
Juan Carlos Ramos
Consulting or Advisory Role - Innate Pharma; Medtrend International; miRagen
 
Joseph A. Sparano
Stock and Other Ownership Interests - Metastat
Consulting or Advisory Role - AstraZeneca; Celgene; Celldex; Genentech/Roche; Juno Therapeutics; Lilly; Merrimack; Novartis; Pfizer; Prescient Therapeutics
Research Funding - Deciphera (Inst); Genentech/Roche (Inst); Merck (Inst); Merrimack (Inst); Novartis (Inst); Novartis (Inst); Prescient Therapeutics (Inst)
 
Page C. Moore
No Relationships to Disclose
 
Ethel Cesarman
No Relationships to Disclose
 
Erin G. Reid
Research Funding - Genentech (I); Millennium
 
Paul G. Rubinstein
No Relationships to Disclose
 
Robert D Harrington
No Relationships to Disclose
 
Robert A. Baiocchi
Consulting or Advisory Role - Theravectys; Viracta Therapeutics
Research Funding - Essenex; Prelude Therapeutics; Viracta Therapeutics
Patents, Royalties, Other Intellectual Property - Prelude Therapeutics
 
David Michael Aboulafia
No Relationships to Disclose
 
Lee Ratner
No Relationships to Disclose
 
Kaplan Lawrence
No Relationships to Disclose
 
Christine Durand
Consulting or Advisory Role - Gilead Sciences; Merck
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Merck; ViiV Healthcare
 
Richard Ambinder
No Relationships to Disclose
 
Jeanette Y. Lee
No Relationships to Disclose
 
Ronald T. Mitsuyasu
Stock and Other Ownership Interests - Amgen
Research Funding - Calimmune (Inst); Sangamo Bioscience (Inst)
 
Ariela Noy
Honoraria - Janssen Oncology
Speakers' Bureau - Prime Oncology
Research Funding - Pharmacyclics
Travel, Accommodations, Expenses - Janssen Oncology; Pharmacyclics